Emerging Tech
A brain implant you could get with a shot in your arm
An MIT lab is working to make brain implants as simple as a vaccine—and it could eventually lead to human augmentation.
Saira Mueller is a senior culture and technology editor who's spent the last decade exploring how digital life rewires our workdays, our brains, and occasionally our love lives. Before joining Morning Brew, she wrote and edited for WIRED, CNN, and Vox Media, covering everything from video games to big tech and the strange ways digital habits spill into the real world. When she's not interrogating the future of tech, she's usually powering through an audiobook while walking her dog, Asteria, or trying to convince her friends to go see yet another Broadway show with her. She's Australian and German, is based in New York, and firmly believes that the best tech stories are really people stories wearing slightly nerdier outfits.
Consumer Electronics
Apple joins the fold
The new iPhone Duo has been announced, and in true Apple fashion, it could shake up the industry with its detailed engineering and little flourishes.
AI
A few AI prompts to help you actually understand your work data
Here are three AI prompts to help you get the most out of your data.
Consumer Electronics
Loud and clear (and never too loud)
We put Bose's new Lifestyle Ultra Soundbar to the test—especially its AI features.
Consumer Electronics
The features coming to your Apple devices soon
Here are the major announcements from WWDC, including the new Siri AI.
Platforms
Nvidia's CPU era has arrived
Agentic AI is creating new demand for CPUs—and Nvidia's are starting to roll out the door.
AI
Joanna Stern’s “Great Gen AI Experiment”
An excerpt from Stern’s upcoming book, “I Am Not A Robot: My Year Using AI To Do (Almost) Everything.”
Life Hacks
How to set up Projects in AI chatbots
We break down what Projects are and how to set them up in ChatGPT, Claude, and Gemini.
AI
Big Pharma's AI bet comes with fine print
Eli Lilly's $2.75 billion deal with AI drug startup Insilico Medicine is mostly contingent on milestones, since no AI-discovered drug has cleared FDA approval yet.
AI
The never-ending year of efficiency
The new equation across Big Tech is: fewer people, more compute.